Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. 144 Insider Sale of Securities
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. ARS Other Annual Report to Security Holders
  4. EFFECT Other Notice of Effectiveness
  5. 144 Insider Sale of Securities
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. ARS Other Annual Report to Security Holders
  8. EFFECT Other Notice of Effectiveness
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. ARS Other Annual Report to Security Holders
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. EFFECT Other Notice of Effectiveness
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. FWP Offering Free Writing Prospectus
  15. EFFECT Other Notice of Effectiveness
  16. CERT Other Certification
  17. 8-A12B Other Registration of Securities
  18. DRSLTR Other Correspondence Related to Draft Registration Statement
  19. DRS/A Other Draft Registration Statement
  20. DRS/A Other Draft Registration Statement

Page 1 of 2 · 22 filings